The identification of apoptosis-related residues in human thymosin beta-10 by mutational analysis and computational modeling.
Thymosin beta-10 (TB10) is an actin monomer-sequestering peptide that consists of 43 amino acid residues and that tends to form alpha-helical structures. Previously, we showed that the overexpression of TB10 dramatically increases the frequency of apoptosis in human ovarian cancer cells. To identify the critical residues responsible for TB10-mediated apoptosis, we used a series of computational methods. First, a three-dimensional structure of human TB10 was constructed using the homology modeling method with the calf thymosin beta-9 NMR structure as a template. Although the sequences of both of these structures are almost identical, 200-ps molecular dynamics simulation results showed that their secondary structures differ. Analyses of molecular dynamics snapshot structures suggested that the TB10 structure is conformationally more complicated than the TB9 structure. The conserved 17LKKTET(22 motif region of TB10 was tested by Ala and Ser scanning mutagenesis using computational and biochemical methods, and 12 mutants were transfected into cancer cell lines and tested for their effects on growth arrest. Of the 12 mutants examined, only the Thr20 to Ser20 mutation showed reduced growth arrest. These results strongly suggest that Thr20 is specifically required for actin sequestration by TB10 in ovarian cancer cells. These results may provide useful information for the development of a new ovarian cancer therapy.
Rho
Seung Bae
SB
Molecular Therapy Research Center, Sungkyunkwan University, Samsung Medical Center Annex 8F, 50 Ilwon-Dong, Kangnam-Ku, Seoul 135-710, Korea.
Lee
Keun Woo
KW
Chun
Taehoon
T
Lee
Seung-Hoon
SH
Park
Kyoungsook
K
Lee
Je-Ho
JH
D000199:Actins / Q000378:metabolism; D017209:Apoptosis / Q000235:genetics* / Q000502:physiology; D019295:Computational Biology; D004252:DNA Mutational Analysis; D005260:Female; D006801:Humans; D008958:Models, Molecular; D015394:Molecular Structure; D016297:Mutagenesis, Site-Directed; D010051:Ovarian Neoplasms / Q000235:genetics / Q000473:pathology; D013912:Threonine / Q000378:metabolism; D013947:Thymosin / Q000737:chemistry / Q000235:genetics* / Q000502:physiology*; D014407:Tumor Cells, Cultured
D000199:Actins; D013912:Threonine; D013947:Thymosin; C039302:thymosin beta(10)